The PRECISE Protocol: Prospective Randomized Trial of the Optimal Evaluation of Cardiac Symptoms and Revascularization

NCT03702244 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

2103

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronary Artery Disease

Interventions

DIAGNOSTIC_TEST: cCTA with selective FFRct

Sponsor

HeartFlow, Inc.

Collaborators

[object Object]
[object Object]